The metastatic renal cell carcinoma (MaRCC) Registry: a prospective academic and community-based study of metastatic renal cell cancer patients

被引:0
|
作者
Bhavsar, Nrupen A. [1 ]
Harrison, Michael R. [1 ]
Hirsch, Bradford R. [2 ]
Creel, Patricia [1 ]
Wolf, Steve P. [1 ]
Samsa, Greg P. [1 ]
Richardson, Eric M. [3 ]
Johnson, Kathleen A. [3 ]
Borham, Azah [4 ]
George, Daniel J. [1 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] US Oncol, Dallas, TX USA
[3] CPI Global CRO, Princeton, NJ USA
[4] Pfizer Inc, New York, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3 / 4
页数:2
相关论文
共 50 条
  • [1] Design and Rationale of the Metastatic Renal Cell Carcinoma (MaRCC) Registry: A Prospective Academic and Community-Based Study of Patients With Metastatic Renal Cell Cancer
    Bhavsar, Nrupen A.
    Harrison, Michael R.
    Hirsch, Bradford R.
    Creel, Patricia
    Wolf, Steve P.
    Samsa, Greg P.
    Abernethy, Amy P.
    Simantov, Ronit
    Borham, Azah
    George, Daniel J.
    [J]. CANCER INVESTIGATION, 2017, 35 (05) : 333 - 344
  • [2] Physician treatment selection in the prospective metastatic renal cell cancer (MaRCC) registry
    Costello, Brian A.
    Harrison, Michael R.
    Bhavsar, Nrupen A.
    Wolf, Steven P.
    Kyriakopoulos, Christos E.
    Stadler, Walter M.
    Hammers, Hans Joerg
    Vaishampayan, Ulka
    Appleman, Leonard J.
    Creel, Patricia
    Samsa, Greg P.
    Richardson, Eric M.
    Johnson, Kathleen A.
    Borham, Azah
    George, Daniel J.
    [J]. BJU INTERNATIONAL, 2015, 116 : 7 - 7
  • [3] Physician treatment selection in the prospective Metastatic Renal Cell Cancer (MaRCC) Registry.
    Kyriakopoulos, Christos
    Harrison, Michael Roger
    Bhavsar, Nrupen Anjan
    Wolf, Steven Paul
    Costello, Brian Addis
    Stadler, Walter Michael
    Hammers, Hans J.
    Vaishampayan, Ulka N.
    Appleman, Leonard Joseph
    Creel, Patricia A.
    Samsa, Greg P.
    Richardson, Eric M.
    Johnson, Kathleen A.
    Borham, Azah
    George, Daniel J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [4] Front-line management patterns in the prospective metastatic renal cell cancer (MaRCC) registry
    Harrison, Michael R.
    Bhavsar, Nrupen A.
    Wolf, Steve P.
    Costello, Brian A.
    Stadler, Walter M.
    Hammers, Hans Joerg
    Vaishampayan, Ulka
    Appleman, Leonard J.
    Tsao, Che-Kai
    Creel, Patricia
    Samsa, Greg P.
    Richardson, Eric M.
    Johnson, Kathleen A.
    Barham, Azah
    George, Daniel J.
    [J]. BJU INTERNATIONAL, 2015, 116 : 12 - 12
  • [5] Deferred systemic therapy (DST) in the prospective metastatic renal cell cancer (MaRCC) registry.
    Harrison, Michael Roger
    Bhaysar, Nrupen Anjan
    Wolf, Steven Paul
    Costello, Brian Addis
    Vaishampayan, Ulka N.
    Kyriakopoulos, Christos
    Stadler, Walter Michael
    Hammers, Hans J.
    Appleman, Leonard Joseph
    Tsao, Che-Kai
    Pal, Sumanta K.
    Hussain, Arif
    Jim, Heather S. L.
    Borham, Azah
    George, Daniel J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Front-line management patterns in the prospective metastatic renal cell cancer (MaRCC) registry.
    Harrison, Michael Roger
    Bhavsar, Nrupen Anjan
    Wolf, Steven Paul
    Costello, Brian Addis
    Stadler, Walter Michael
    Hammers, Hans J.
    Vaishampayan, Ulka N.
    Appleman, Leonard Joseph
    Tsao, Che-Kai
    Creel, Patricia A.
    Samsa, Greg P.
    Richardson, Eric M.
    Johnson, Kathleen A.
    Borham, Azah
    George, Daniel J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [7] Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)
    Harrison, Michael R.
    Costello, Brian A.
    Bhavsar, Nrupen A.
    Vaishampayan, Ulka
    Pal, Sumanta K.
    Zakharia, Yousef
    Jim, Heather S. L.
    Fishman, Mayer N.
    Molina, Ana M.
    Kyriakopoulos, Christos E.
    Tsao, Che-Kai
    Appleman, Leonard J.
    Gartrell, Benjamin A.
    Hussain, Arif
    Stadler, Walter M.
    Agarwal, Neeraj
    Pachynski, Russell K.
    Hutson, Thomas E.
    Hammers, Hans J.
    Ryan, Christopher W.
    Inman, Brant A.
    Mardekian, Jack
    Borham, Azah
    George, Daniel J.
    [J]. CANCER, 2021, 127 (13) : 2204 - 2212
  • [8] Re: Active Surveillance of Metastatic Renal Cell Carcinoma: Results from a Prospective Observational Study (MaRCC)
    Harrison, M. R.
    Costello, B. A.
    Bhavsar, N. A.
    Vaishampayan, U.
    Pal, S. K.
    Zakharia, Y.
    Jim, H. S. L.
    Fishman, M. N.
    Molina, A. M.
    Kyriakopoulos, C. E.
    Tsao, C. -K.
    Appleman, L. J.
    Gartrell, B. A.
    Hussain, A.
    Stadler, W. M.
    Agarwal, N.
    Pachynski, R. K.
    Hutson, T. E.
    Hammers, H. J.
    Ryan, C. W.
    Inman, B. A.
    Mardekian, J.
    Borham, A.
    George, D. J.
    [J]. JOURNAL OF UROLOGY, 2021, 206 (06): : 1515 - 1516
  • [9] A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience
    Costello, Brian A.
    Bhavsar, Nrupen A.
    Zakharia, Yousef
    Pal, Sumanta K.
    Vaishampayan, Ulka
    Jim, Heather
    Fishman, Mayer N.
    Molina, Ana M.
    Kyriakopoulos, Christos E.
    Tsao, Che-Kai
    Appleman, Leonard J.
    Gartrell, Benjamin A.
    Hussain, Arif
    Stadler, Walter M.
    Agarwal, Neeraj
    Pachynski, Russell K.
    Hutson, Thomas E.
    Hammers, Hans J.
    Ryan, Christopher W.
    Mardekian, Jack
    Borham, Azah
    George, Daniel J.
    Harrison, Michael R.
    [J]. CLINICAL GENITOURINARY CANCER, 2022, 20 (01) : 1 - 10
  • [10] Prospective front-line management patterns in the Real World Metastatic Renal Cell Cancer (MaRCC) Registry.
    Harrison, Michael Roger
    Bhavsar, Nrupen Anjan
    Wolf, Steven Paul
    Costello, Brian Addis
    Vaishampayan, Ulka N.
    Kyriakopoulos, Christos
    Stadler, Walter Michael
    Hammers, Hans J.
    Appleman, Leonard Joseph
    Tsao, Che-Kai
    Pal, Sumanta K.
    Hussain, Arif
    Jim, Heather S. L.
    Borham, Azah
    George, Daniel J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)